Citation
Kumar, Sourav, et al. "A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in in Vitro SH-SY5Y Cells." Current Alzheimer Research, vol. 14, no. 12, 2017, pp. 1293-1304.
Kumar S, Paul A, Kalita S, et al. A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells. Curr Alzheimer Res. 2017;14(12):1293-1304.
Kumar, S., Paul, A., Kalita, S., Kumar, A., Srivastav, S., Hazra, S., Ghosh, A. K., Mandal, B., & Mondal, A. C. (2017). A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells. Current Alzheimer Research, 14(12), 1293-1304. https://doi.org/10.2174/1567205014666170713153414
Kumar S, et al. A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in in Vitro SH-SY5Y Cells. Curr Alzheimer Res. 2017;14(12):1293-1304. PubMed PMID: 28714389.
TY - JOUR
T1 - A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells.
AU - Kumar,Sourav,
AU - Paul,Ashim,
AU - Kalita,Sourav,
AU - Kumar,Awanish,
AU - Srivastav,Saurabh,
AU - Hazra,Somoday,
AU - Ghosh,Anup Kumar,
AU - Mandal,Bhubaneswar,
AU - Mondal,Amal Chandra,
PY - 2017/03/07/received
PY - 2017/04/13/revised
PY - 2017/06/29/accepted
PY - 2017/7/18/pubmed
PY - 2018/6/22/medline
PY - 2017/7/18/entrez
KW - Alzheimer's disease
KW - SH-SY5Y cells.
KW - amyloid-β
KW - apoptosis
KW - pro-drug peptide
KW - reactive oxygen species
SP - 1293
EP - 1304
JF - Current Alzheimer research
JO - Curr Alzheimer Res
VL - 14
IS - 12
N2 - BACKGROUND: Alzheimer's disease (AD), a common protein misfolding progressive neurodegenerative disorder, is one of the most common forms of dementia. Amyloid precursor protein (APP) derived amyloid-β (Aβ) protein accumulate into interneuronal spaces and plays a crucial role in the disease progression and its pathology. The aggregated Aβ exerts its neurotoxic effects by inducing apoptosis and oxidative damage in neuronal cells. OBJECTIVES: We have investigated the effects of a synthesized Pro-Drug peptide (PDp) on Aβ1-40 induced cytotoxicity in human neuroblastoma SH-SY5Y cells, represents one of the most effective strategies in combating human AD. METHODS: Cells were treated with Aβ1-40 to induce cytotoxicity in the experimental model of AD to screen the inhibitory effect of PDp. Assays for cell viability, reactive oxygen species (ROS) generation, levels of intracellular free Ca2+ and expression of key apoptotic proteins were assessed by Western Blotting. RESULTS: Our results showed that Aβ1-40 induces for 24h caused reduce cell viability, imbalance in Ca2+ homeostasis and increase in neuronal apoptosis in vitro. Treatment with PDp could effectively ameliorated Aβ1-40 induced neurotoxicity and attenuates ROS generation that mediates apoptotic signaling through Bcl-2, Bax, Caspase-3 activity and cytochrome c in the cells. CONCLUSION: These findings suggested that PDp has potential role as a neuroprotective and therapeutic agent for combating human AD.
SN - 1875-5828
UR - https://www.unboundmedicine.com/medline/citation/28714389/A_Peptide_Based_Pro_Drug_Ameliorates_Amyloid_β_Induced_Neuronal_Apoptosis_in_In_Vitro_SH_SY5Y_Cells_
L2 - https://www.ingentaconnect.com/openurl?genre=article&issn=1567-2050&volume=14&issue=12&spage=1293&aulast=Kumar
DB - PRIME
DP - Unbound Medicine
ER -